Metraipolis › archive › dc_aafcd741b9bf

Paradoxical Use of Benralizumab in Reactive Hypereosinophilia from Toxocariasis and Tuberculosis Co-Infection-Case Report and Literature Review — Europe PMC PMID:40943043

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40943043
DOI
10.3390/ijms26178117
License (as archived)
solo-consultazione
Archived
2026-11-10T10:27:11.578Z
SHA-256 of the archived text
adad9c05320ce79acb18c1155bd48b261400190864549d43ee5693f4d4cbfffd
Stable URL of this page
https://metraipolis.com/documento/dc_aafcd741b9bf

How to cite

Paradoxical Use of Benralizumab in Reactive Hypereosinophilia from Toxocariasis and Tuberculosis Co-Infection-Case Report and Literature Review — Europe PMC PMID:40943043 — Europe PMC (en), https://europepmc.org/article/MED/40943043 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aafcd741b9bf (Metraipolis archive dc_aafcd741b9bf, sha256 adad9c05320ce79acb18c1155bd48b261400190864549d43ee5693f4d4cbfffd)
BibTeX
@misc{dcaafcd741b9bf,
  title = {Paradoxical Use of Benralizumab in Reactive Hypereosinophilia from Toxocariasis and Tuberculosis Co-Infection-Case Report and Literature Review — Europe PMC PMID:40943043},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40943043},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aafcd741b9bf; sha256 adad9c05320ce79acb18c1155bd48b261400190864549d43ee5693f4d4cbfffd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40943043. Agents can read the archived copy with the MCP tool read_document.